News

On the basis of a share transfer agreement dated 4 April with the partner company of Croatia Osiguranje, Croatian diversified holding company Adris Grupa [ZSE: ADRS, ADRS2], Croatia Osiguranje ...
The SAVA Center, which responded to over 1,000 hotline calls in 2024, discovered about a week and a half ago that its toll-free crisis line had been disconnected without warning or request ...
Welcome to The A.V. Club’s monthly comics preview, where we recommend new books to check out over the next few weeks. This month, we’ve got five exciting picks, including new G.I. Joe stories ...
The South African Veterinary Association (SAVA) has raised urgent alarms about the recent suspension of funding from the United States Agency for International Development (USAID). The association ...
Nicolas Girard, MD, PhD, discusses data from the COCOON trial for patients with EGFR-mutant advanced non–small cell lung cancer. Nicolas Girard, MD, PhD, a thoracic oncologist at the Institut Curie in ...
Among these, Cassava Sciences, Inc SAVA nosedived following the failure of a late-stage study, while Alnylam Pharmaceuticals ALNY gained following FDA nod for label expansion of its key drug.
Nicolas Girard, MD, PhD, discusses the final overall survival results from the MARIPOSA trial of amivantamab plus lazertinib in EGFR-mutant advanced non–small cell lung cancer. Nicolas Girard, MD, PhD ...
Cassava Sciences (NASDAQ:SAVA) lost ~19% in the premarket on Tuesday after the company announced plans to discontinue its research program for its lead asset simufilam in Alzheimer’s disease by ...
including tuberous sclerosis complex. Price Action: SAVA stock is down 22.1% at $2.18 at the last check Tuesday.
Africa Specialty Risks (ASR) has entered into binding authority agreements with Sava Re, enabling the Slovenian reinsurance group to provide capacity across ASR’s core lines of business.